Quantcast

Posts related to ‘BIIB’

BioHealth Business Daily (ACUR, AMLN, BIIB, ELN, CADX, CYCC, HGSI, MIPI, PRAN, RNN, SQNM)

Posted: April 20, 2010 at 3:14 pm

Today's version of the BioHealth Business Daily is again full of stocks on the move with news, and some not on news.  Array BioPharma, Inc. (NASDAQ: ARRY), BioDelivery Services International ...
Read Full Story »

BioHealth Business Daily (ACUR, AMLN, BIIB, ELN, CADX, CYCC, HGSI, MIPI, PRAN, RNN, SQNM)

Posted: April 19, 2010 at 3:20 pm

Today's version of the BioHealth Business Daily has many stocks moving on news, but oddly many of the real news stocks are hardly moving and were eliminated from today's report.  ...
Read Full Story »

Today’s Best Market Rumors (3/23/2010)

Posted: March 23, 2010 at 7:47 am

Updated thoughout the day. Carl Icahn will push for the sale of Biogen (BIIB) (Bloomberg) Buffett's Berkshire Hathaway (BRK.B) may be more liquor distributors after picked up Empire  (Bloomberg) Nintendo ...
Read Full Story »

BioHealth Business Daily (CTIC, DNDN, MNKD, VPHM, SOMX, SQNM, TEVA, RNN, BIIB)

Posted: March 22, 2010 at 12:57 pm

Monday is seeing many winners and losers in the healthcare sector on the heels of the health care reform passage in the House of Representatives this weekend.  We are focusing ...
Read Full Story »

Top 10 Analyst Upgrades and Downgrades (ABT, ARO, BIIB, CELG, CADC, FACT, HBC, LMNX, EDU, SGI)

Posted: March 12, 2010 at 8:38 am

These are this Friday’s top analyst upgrades, downgrades, and initiations seen from Wall Street morning research calls: Abbott Laboratories (NYSE: ABT) Cut to Sell at Citigroup. Aeropostale (NYSE: ARO) Raised ...
Read Full Story »

Top 10 Analyst Upgrades and Downgrades (BIIB, CMA, ENER, ESLR, FSLR, MAT, HK, TRV, YUM, ZRAN)

Posted: March 9, 2010 at 8:17 am

These are this Tuesday morning's top analyst upgrades, downgrades, and initiations seen in early Wall Street research notes: Biogen Idec (NASDAQ: BIIB) Started as Buy at Soleil. Comerica (NYSE: CMA) ...
Read Full Story »

Unusual Options Trading Alerts (AAPL, GOOG, AMZN, RIMM, GLD, BIIB, MU)

Posted: December 21, 2009 at 1:42 pm

We have compiled several options chains we are watching today now that the DEC-2009 PUTS/CALLS have expired on Friday.  Much of this likely options roll-outs continuing, but we are seeing ...
Read Full Story »

Top 10 Analyst Upgrades, Downgrades, Initiations (BIIB, INCY, MOT, CMCSA, JWN, ODP, PALM, RIMM, RCL, YUM)

Posted: November 2, 2009 at 9:25 am

These are this Monday's top ten analyst upgrades, downgrades, and initiations seen from Wall Street research firms: Biogen Idec (NASDAQ: BIIB) Raised to Buy at Jefferies. Incyte Corporation (NASDAQ: INCY) ...
Read Full Story »

BioTech Hostile Takeover: Biogen Plays For Facet

Posted: September 4, 2009 at 3:48 pm

Facet Biotech Corporation (FACT) confirms that it is in receipt of Biogen Idec Inc.'s (BIIB) letter dated September 4, 2009 offering $14.50 per share for all of the outstanding shares ...
Read Full Story »

Top Analyst Upgrades and Downgrades (BIIB, FRX, GENZ, GILD, HOLX, LVS, MOS, NVAX, RIG, TXT)

Posted: September 2, 2009 at 8:21 am

These are the top ten analyst research initiations, upgrades, and downgrades we have seen from top Wall Street firms early this Wednesday morning: Biogen-Idec (BIIB) Started as Underperform at BofA/Merrill ...
Read Full Story »
Biotech Image

When Key Biotechs Have Low P/E’s & Value Screens (AMGN, BIIB, CEPH, CBST, GENZ, PDLI)

Posted: August 24, 2009 at 9:54 am

It usually takes an event or a series of events for biotech stocks to ever look cheap compared to the overall market or even to sub-sectors within health care.  They ...
Read Full Story »
newspaper

Media Digest 8/7/2009 Reuters, WSJ, NY Times, FT, Bloomberg

Posted: August 7, 2009 at 4:05 am

Reuters:   A college education no longer means easy employment in China. Reuters:   Fannie Mae (FNM) lost $14.8 billion. Reuters:   The auto "clunkers" legislation passed the Senate. Reuters:   Obama is in ...
Read Full Story »
biotech

The Next Blockbuster Drugs: A $170 Billion Opportunity

Posted: July 22, 2009 at 4:01 am

Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line data, a new biotech-based treatment, and a massive potential ...
Read Full Story »

Biotech Business Daily (BIIB, VRTX, ALNY, STEM)

Posted: July 10, 2009 at 10:07 am

Here are some of the top stories affecting key drug and biotech stocks this Friday.  We also have links through to more detailed coverage and analysis at BioHealthInvestor.com: Biogen Idec ...
Read Full Story »

Biotech Business Daily (RIGL, BIIB, ARRY, ALNY, FOLD, HALO, AOB, STEM)

Posted: July 9, 2009 at 11:09 am

Here are some of the top stories affecting key drug and biotech stocks that have links through to more in-depth coverage and analysis today at the website BioHealthInvestor.com: Rigel Pharmaceuticals ...
Read Full Story »